MCI-186 Inhibits Tumor Growth Through Suppression of EGFR Phosphorylation and Cell Cycle Arrest
Background: It has been suggested that radicals stimulate tumor cell growth. We examined if the hydroxyl radical scavenger, 3-methyl-1-phenyl-2-pyrazolin-5-one (MCI-186), affects tumor growth in vitro. Materials and Methods: Human hepatocarcinoma HepG2, mesothelioma MSTO-211H, gastric carcinoma TMK-...
Gespeichert in:
Veröffentlicht in: | Anticancer research 2005-03, Vol.25 (2A), p.1131-1138 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Background: It has been suggested that radicals stimulate tumor cell growth. We examined if the hydroxyl radical scavenger,
3-methyl-1-phenyl-2-pyrazolin-5-one (MCI-186), affects tumor growth in vitro. Materials and Methods: Human hepatocarcinoma
HepG2, mesothelioma MSTO-211H, gastric carcinoma TMK-1 and breast carcinoma MCF-7 were used for cell proliferation assay.
Cell cycle analysis was performed using propidium iodide for fluorescence activated cell sorter. By Western blotting, EGF
receptor (EGFR) phosphorylation and EGFR expression were analyzed. Results: Growth inhibition was observed from 10 μM to 300
μM of MCI-186 in a dose-dependent manner. Cell cycle analysis revealed that MCI-186 arrested the cell cycle at the G0/G1-phase.
MCI-186 inhibited EGF-stimulated cell growth. The phosphorylation level of EGFR was decreased by MCI-186, but the EGFR level
was unchanged. Conclusion: From the data obtained, we suggest that tumor inhibition by MCI-186 was due, at least in part,
to the modulation of EGFR signaling and cell cycle arrest. |
---|---|
ISSN: | 0250-7005 1791-7530 |